Last Updated: November 16, 2026

Details for Patent: 11,944,627

« Back to Dashboard


Which drugs does patent 11,944,627 protect, and when does it expire?

Patent 11,944,627 protects KOMZIFTI and is included in one NDA.

This patent has nine patent family members in four countries.

Summary for Patent: 11,944,627
Title:Methods for treating hematological malignancies and Ewing's sarcoma
Abstract:The present disclosure provides methods for treating hematological malignancies and Ewings sarcoma using menin inhibitors. Compositions for use in these methods are also provided.
Inventor(s):Francis Burrows, Linda V. KESSLER, Liansheng Li, Pingda Ren, Yi Wang, Tao Wu, Jingchuan Zhang
Assignee: Wellspring Biosciences LLC , Kura Oncology Inc
Application Number:US16/494,556
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 11,944,627

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Kura KOMZIFTI ziftomenib CAPSULE;ORAL 220305-001 Nov 13, 2025 RX Yes Yes 11,944,627 ⤷  Start Trial METHOD OF TREATING ACUTE MYELOID LEUKEMIA ⤷  Start Trial
Kura KOMZIFTI ziftomenib CAPSULE;ORAL 220305-001 Nov 13, 2025 RX Yes Yes 11,944,627 ⤷  Start Trial METHOD OF TREATING ACUTE MYELOID LEUKEMIA WITH ZIFTOMENIB OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,944,627

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 110691779 ⤷  Start Trial
China 117298275 ⤷  Start Trial
European Patent Office 3601249 ⤷  Start Trial
Japan 2020514388 ⤷  Start Trial
Japan 2023055735 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.